{"organizations": [], "uuid": "b8256df15268436b34bf5e864a427ace1ccaabf8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180306.html", "section_title": "Archive News &amp; Video for Tuesday, 06 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-us-fda-approves-new-hiv-treatment/brief-u-s-fda-approves-new-hiv-treatment-for-patients-who-have-limited-treatment-options-idUSFWN1QO0PN", "country": "US", "domain_rank": 408, "title": "BRIEF-U.S. FDA Approves New HIV Treatment For Patients Who Have Limited Treatment Options", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.7, "site_type": "news", "published": "2018-03-07T02:23:00.000+02:00", "replies_count": 0, "uuid": "b8256df15268436b34bf5e864a427ace1ccaabf8"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-us-fda-approves-new-hiv-treatment/brief-u-s-fda-approves-new-hiv-treatment-for-patients-who-have-limited-treatment-options-idUSFWN1QO0PN", "ord_in_thread": 0, "title": "BRIEF-U.S. FDA Approves New HIV Treatment For Patients Who Have Limited Treatment Options", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "taimed", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "u.s. food and drug administration", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "biologics usa corp", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 6 (Reuters) - U.S. Food and Drug Administration:\n* U.S. FDA SAYS APPROVED ANTIRETROVIRAL MEDICATION TROGARZO (IBALIZUMAB-UIYK) FOR ADULT HIV PATIENTS WHO HAVE TRIED MULTIPLE HIV MEDICATIONS BEFORE\n* U.S. FDA SAYS GRANTED APPROVAL OF TROGARZO TO TAIMED BIOLOGICS USA CORP Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-07T02:23:00.000+02:00", "crawled": "2018-03-07T19:25:05.008+02:00", "highlightTitle": ""}